NPY4R
Neuropeptide Y receptor type 4
Also known as: NPY4R_HUMAN, PP1, PPYR1, Y4
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P50391
- Gene
- NPY4R
- Ensembl
- ENSG00000204174
- Chromosome
- 10
- Canonical length
- 375 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
OverviewNCBI Gene
Enables pancreatic polypeptide receptor activity and peptide hormone binding activity. Involved in G protein-coupled receptor signaling pathway. Located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
375 residues, UniProt reviewed canonical sequence.
>P50391|NPY4R
1 MNTSHLLALL LPKSPQGENR SKPLGTPYNF SEHCQDSVDV MVFIVTSYSI ETVVGVLGNL
61 CLMCVTVRQK EKANVTNLLI ANLAFSDFLM CLLCQPLTAV YTIMDYWIFG ETLCKMSAFI
121 QCMSVTVSIL SLVLVALERH QLIINPTGWK PSISQAYLGI VLIWVIACVL SLPFLANSIL
181 ENVFHKNHSK ALEFLADKVV CTESWPLAHH RTIYTTFLLL FQYCLPLGFI LVCYARIYRC
241 LQRQGRVFHK GTYSLRAGHM KQVNVVLVVM VVAFAVLWLP LHVFNSLEDW HHEAIPICHG
301 NLIFLVCHLL AMASTCVNPF IYGFLNTNFK KEIKALVLTC QQSAPLEESE HLPLSTVHTE
361 VSKGSLRLSG RSNPILocalizationUniProt · AlphaFold · HPA
Whether an antibody against NPY4R can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 5.6 nTPM
Expression across tissuesHPA
Tissue
- rectum: 5.6 nTPM
- colon: 4.6 nTPM
- skin: 2.8 nTPM
- stomach: 1.8 nTPM
- duodenum: 1.4 nTPM
- prostate: 1.3 nTPM
Single-cell type
- epicardial cells: 2.3 nCPM
- colonocytes: 0.1 nCPM
- mesothelial cells: 0.1 nCPM
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 4.8 nTPM
- thalamus: 2.7 nTPM
- medulla oblongata: 1.7 nTPM
- cerebellum: 1.5 nTPM
- midbrain: 1.5 nTPM
- pons: 1.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.75
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.14
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- G protein-coupled receptor activity
- neuropeptide binding
- pancreatic polypeptide receptor activity
- peptide hormone binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NPY4R as an antibody target. Whether an autoantibody or antibody against NPY4R could matter depends on whether native NPY4R is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NPY4R is annotated at the cell surface, where native NPY4R is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NPY4R as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...